These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 27108105)
21. Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review. Nguyen AH; Detty SQ; Agrawal DK Anticancer Res; 2017 Jan; 37(1):1-7. PubMed ID: 28011467 [TBL] [Abstract][Full Text] [Related]
22. HMGB1 regulates P-glycoprotein expression in status epilepticus rat brains via the RAGE/NF-κB signaling pathway. Xie Y; Yu N; Chen Y; Zhang K; Ma HY; Di Q Mol Med Rep; 2017 Aug; 16(2):1691-1700. PubMed ID: 28627626 [TBL] [Abstract][Full Text] [Related]
23. Disulfide high mobility group box-1 causes bladder pain through bladder Toll-like receptor 4. Ma F; Kouzoukas DE; Meyer-Siegler KL; Westlund KN; Hunt DE; Vera PL BMC Physiol; 2017 May; 17(1):6. PubMed ID: 28545586 [TBL] [Abstract][Full Text] [Related]
24. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). van Beijnum JR; Buurman WA; Griffioen AW Angiogenesis; 2008; 11(1):91-9. PubMed ID: 18264787 [TBL] [Abstract][Full Text] [Related]
25. Blockade of HMGB1 Attenuates Diabetic Nephropathy in Mice. Chen X; Ma J; Kwan T; Stribos EGD; Messchendorp AL; Loh YW; Wang X; Paul M; Cunningham EC; Habib M; Alexander IE; Sharland AF; Chadban SJ; Wu H Sci Rep; 2018 May; 8(1):8319. PubMed ID: 29844451 [TBL] [Abstract][Full Text] [Related]
26. Expression of High Mobility Group Protein B1 in Cardiac Tissue of Elderly Patients with Coronary Artery Disease with or without Inflammatory Rheumatic Disease. Bruton M; Hollan I; Xiao J; Lindroos E; Mikkelsen K; Rynning SE; Saatvedt K; Almdahl SM; Harris HE; Lundberg IE; Wick C Gerontology; 2017; 63(4):337-349. PubMed ID: 28427050 [TBL] [Abstract][Full Text] [Related]
27. Implication of HMGB1 signaling pathways in Amyotrophic lateral sclerosis (ALS): From molecular mechanisms to pre-clinical results. Paudel YN; Angelopoulou E; Piperi C; Othman I; Shaikh MF Pharmacol Res; 2020 Jun; 156():104792. PubMed ID: 32278047 [TBL] [Abstract][Full Text] [Related]
28. Trimebutine attenuates high mobility group box 1-receptor for advanced glycation end-products inflammatory signaling pathways. Nakajima S; Ogawa N; Yokoue N; Tachibana H; Tamada K; Okazawa M; Sato A; Oyama T; Abe H; Kamiya T; Yoshimori A; Yoshizawa K; Inoue S; Yokomizo T; Uchiumi F; Abe T; Tanuma SI Biochem Biophys Res Commun; 2020 Dec; 533(4):1155-1161. PubMed ID: 33041002 [TBL] [Abstract][Full Text] [Related]
29. Early release of HMGB-1 from neurons after the onset of brain ischemia. Qiu J; Nishimura M; Wang Y; Sims JR; Qiu S; Savitz SI; Salomone S; Moskowitz MA J Cereb Blood Flow Metab; 2008 May; 28(5):927-38. PubMed ID: 18000511 [TBL] [Abstract][Full Text] [Related]
30. Persistent Increase in Microglial RAGE Contributes to Chronic Stress-Induced Priming of Depressive-like Behavior. Franklin TC; Wohleb ES; Zhang Y; Fogaça M; Hare B; Duman RS Biol Psychiatry; 2018 Jan; 83(1):50-60. PubMed ID: 28882317 [TBL] [Abstract][Full Text] [Related]
31. Up-regulation of HMGB1 and TLR4 in skin lesions of lichen planus. de Carvalho GC; Hirata FYA; Domingues R; Figueiredo CA; Zaniboni MC; Pereira NV; Sotto MN; Aoki V; da Silva Duarte AJ; Sato MN Arch Dermatol Res; 2018 Aug; 310(6):523-528. PubMed ID: 29728859 [TBL] [Abstract][Full Text] [Related]
32. Pivotal role of high-mobility group box 1 (HMGB1) signaling pathways in glioma development and progression. Angelopoulou E; Piperi C; Adamopoulos C; Papavassiliou AG J Mol Med (Berl); 2016 Aug; 94(8):867-74. PubMed ID: 27262996 [TBL] [Abstract][Full Text] [Related]
33. HMGB1 Contributes to the Expression of P-Glycoprotein in Mouse Epileptic Brain through Toll-Like Receptor 4 and Receptor for Advanced Glycation End Products. Chen Y; Huang XJ; Yu N; Xie Y; Zhang K; Wen F; Liu H; Di Q PLoS One; 2015; 10(10):e0140918. PubMed ID: 26485677 [TBL] [Abstract][Full Text] [Related]
34. Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis. Szczepanski MJ; Luczak M; Olszewska E; Molinska-Glura M; Zagor M; Krzeski A; Skarzynski H; Misiak J; Dzaman K; Bilusiak M; Kopec T; Leszczynska M; Witmanowski H; Whiteside TL J Mol Med (Berl); 2015 Mar; 93(3):305-14. PubMed ID: 25385222 [TBL] [Abstract][Full Text] [Related]
35. Role of High-Mobility Group Box-1 in Liver Pathogenesis. Khambu B; Yan S; Huda N; Yin XM Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731454 [TBL] [Abstract][Full Text] [Related]
36. High-mobility group box 1 inhibits HCO(3)(-) absorption in medullary thick ascending limb through a basolateral receptor for advanced glycation end products pathway. Good DW; George T; Watts BA Am J Physiol Renal Physiol; 2015 Oct; 309(8):F720-30. PubMed ID: 26180239 [TBL] [Abstract][Full Text] [Related]
37. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation. Ullah MA; Loh Z; Gan WJ; Zhang V; Yang H; Li JH; Yamamoto Y; Schmidt AM; Armour CL; Hughes JM; Phipps S; Sukkar MB J Allergy Clin Immunol; 2014 Aug; 134(2):440-50. PubMed ID: 24506934 [TBL] [Abstract][Full Text] [Related]
38. The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules. Mudaliar H; Pollock C; Komala MG; Chadban S; Wu H; Panchapakesan U Am J Physiol Renal Physiol; 2013 Jul; 305(2):F143-54. PubMed ID: 23576640 [TBL] [Abstract][Full Text] [Related]
39. RAGE and TLRs: relatives, friends or neighbours? Ibrahim ZA; Armour CL; Phipps S; Sukkar MB Mol Immunol; 2013 Dec; 56(4):739-44. PubMed ID: 23954397 [TBL] [Abstract][Full Text] [Related]
40. High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4. Nadatani Y; Watanabe T; Tanigawa T; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T Am J Pathol; 2012 Jul; 181(1):98-110. PubMed ID: 22634181 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]